May 19, 2024

Spatial OMICS Market Size to Garner USD 685.12 Million by 2032

The global Spatial OMICS market size was estimated to be around US$ 251.3 million in 2022. It is projected to reach US$ 685.12 million by 2032, indicating a CAGR of 10.60% from 2023 to 2032.

Spatial OMICS Market Size 2023 To 2032

Key Takeaways

  • North America contributed more than 45% of revenue share in 2022.
  • Asia-Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
  • By Application, the Diagnostics segment has held the largest market share of 39% in 2022.
  • By Application, the Translation Research segment is anticipated to grow at a remarkable CAGR of 12.8% between 2023 and 2032.
  • By Solution Type, the Instruments segment generated over 42% of revenue share in 2022.
  • By Solution Type, the Software segment is expected to expand at the fastest CAGR over the projected period.
  • By Sample, the DNA segment generated over 52% of revenue share in 2022.
  • By Sample, the RNA segment is expected to expand at the fastest CAGR over the projected period.
  • By End-user, the Biopharmaceutical & Biotechnological Companies segment had the largest market share of 48% in 2022.
  • By End-user, the Academic and Research Institutions segment is expected to expand at the fastest CAGR over the projected period.

The Spatial OMICS Market refers to the industry related to spatial genomics and other OMICS technologies. “Spatial genomics” involves studying genetic information within its spatial context in tissues or cells, providing a more comprehensive understanding of biological processes. This market likely includes technologies and tools that enable researchers to analyze and visualize the spatial organization of biomolecules, such as genes and proteins, within biological samples. Applications may range from understanding disease mechanisms to drug discovery and personalized medicine. The market is driven by the increasing demand for advanced molecular analysis techniques in the field of genomics.

Get a Sample: https://www.precedenceresearch.com/sample/3517

Growth Factors

The Spatial OMICS market has witnessed substantial growth in recent years, with a notable surge in demand driven by advancements in omics technologies and their application in spatially resolved analysis. The Growth Factor for Spatial OMICS can be attributed to its ability to provide a comprehensive understanding of the spatial organization of biological molecules within tissues. This technology allows researchers to investigate complex biological systems at a single-cell resolution, offering insights into the spatial distribution of genes, proteins, and other biomolecules. The integration of spatial information with traditional omics data enhances our understanding of cellular heterogeneity and interactions within tissues, thereby contributing to advancements in fields such as cancer research, neuroscience, and developmental biology. As the Spatial OMICS market continues to evolve, innovations and collaborations within the scientific community are expected to further propel its growth, opening new avenues for diagnostic and therapeutic applications.

Spatial OMICS Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 10.60%
Market Size in 2023 USD 276.68 Million
Market Size by 2032 USD 685.12 Million
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Application, By Solution Type, By Sample, and By End Users
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Pet Food and Supplements Market Size to Garner USD 179.18 Billion by 2032

North America has held the largest revenue share of 45% in 2022. The North American spatial OMICS market showcases a trend of substantial growth driven by extensive research and development initiatives. Leading academic institutions, biotechnology companies, and pharmaceutical firms are heavily investing in this technology, particularly in precision diagnostics and drug discovery. The region benefits from a robust infrastructure for data analytics and interdisciplinary collaborations, further accelerating advancements in spatial OMICS applications.

Spatial OMICS Market Share, By Region, 2022 (%)

Europe is estimated to observe the fastest expansion. In Europe, the spatial OMICS market is characterized by a strong emphasis on standardization and regulatory compliance. The region is focusing on developing standardized protocols for data collection and analysis, ensuring data accuracy and reproducibility. This commitment to standardization is crucial for fostering trust in spatial OMICS data and its adoption in clinical and regulatory settings. Additionally, European researchers are actively exploring applications in neuroscience and cancer research, contributing to the market’s steady growth.

Recent Developments

  • In 2023, OMAPiX, a spatial omics services provider, has forged collaborations with Vizgen, Resolve Biosciences, and Ultivue, Inc. They will utilize cutting-edge technologies to deliver standardized, high-quality spatial transcriptomic and proteomic data. These partnerships aim to accelerate drug development and life science research by providing valuable insights to customers.
  • In 2023, Bio-Techne and Lunaphore are forming a strategic alliance to develop a fully automated spatial multiomics solution. This partnership aims to create a method for simultaneous identification of protein and RNA biomarkers on a single slide, offering panel design flexibility and facilitating comprehensive disease research.
  • In 2021, NanoString Technologies, Inc. initiated the Technology Access Program (TAP), offering tissue sample analysis using the Spatial Molecular Imager platform and GeoMx Digital Spatial Profiler. This program expands spatial biology applications in the region.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Spatial OMICS Market Players

  • NanoString Technologies, Inc.
  • Illumina, Inc.
  • 10x Genomics, Inc.
  • Akoya Biosciences, Inc.
  • Visiopharm A/S
  • GE Healthcare
  • Fluidigm Corporation
  • Advanced Cell Diagnostics, Inc.
  • PerkinElmer, Inc.
  • ZEISS Group
  • RareCyte, Inc.
  • Bio-Rad Laboratories, Inc.
  • ImaBiotech
  • Indica Labs, Inc.
  • Ultivue, Inc.

Segments Covered in the Report

By Application

  • Diagnostics
  • Translation Research
  • Drug Discovery and Development
  • Single Cell Analysis
  • Cell Biology
  • Other

By Solution Type

  • Instruments
  • Consumables
  • Software

By Sample

  • DNA
  • RNA
  • Protein

By End Users

  • Academic and Research Institutions
  • Biopharmaceutical & Biotechnological Companies
  • Contract Research Organization
  • Other

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Spatial OMICS Market 

5.1. COVID-19 Landscape: Spatial OMICS Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Spatial OMICS Market, By Application

8.1. Spatial OMICS Market Revenue and Volume Forecast, by Application, 2023-2032

8.1.1. Diagnostics

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Translation Research

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Drug Discovery and Development

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Single Cell Analysis

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Cell Biology

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

8.1.6. Other

8.1.6.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Spatial OMICS Market, By Solution Type

9.1. Spatial OMICS Market Revenue and Volume Forecast, by Solution Type, 2023-2032

9.1.1. Instruments

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Consumables

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Software

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Spatial OMICS Market, By Sample 

10.1. Spatial OMICS Market Revenue and Volume Forecast, by Sample, 2023-2032

10.1.1. DNA

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. RNA

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Protein

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Spatial OMICS Market, By End Users 

11.1. Spatial OMICS Market Revenue and Volume Forecast, by End Users, 2023-2032

11.1.1. Academic and Research Institutions

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Biopharmaceutical & Biotechnological Companies

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Contract Research Organization

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

11.1.4. Other

11.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Spatial OMICS Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Solution Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Sample (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End Users (2020-2032)

Chapter 13. Company Profiles

13.1. NanoString Technologies, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Illumina, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. 10x Genomics, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Akoya Biosciences, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Visiopharm A/S

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GE Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Fluidigm Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Advanced Cell Diagnostics, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PerkinElmer, Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. ZEISS Group

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *